4//SEC Filing
Stone Paul A. 4
Accession 0001610717-23-000233
CIK 0001676725other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 6:33 PM ET
Size
7.9 KB
Accession
0001610717-23-000233
Insider Transaction Report
Form 4
Stone Paul A.
SVP, General Counsel
Transactions
- Sale
Common Stock
2023-08-16$26.40/sh−100$2,640→ 19,103 total - Sale
Common Stock
2023-08-18$26.38/sh−3,822$100,820→ 15,281 total - Sale
Common Stock
2023-08-16$26.45/sh−100$2,645→ 19,203 total
Footnotes (2)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 27, 2023.
- [F2]This transaction was executed in multiple trades in prices ranging from $26.37 to $26.415, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
IDEAYA Biosciences, Inc.
CIK 0001676725
Entity typeother
Related Parties
1- filerCIK 0001777511
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 6:33 PM ET
- Size
- 7.9 KB